A newly developed vaccine against a group of viruses including SARS-CoV-2 is producing promising results in mice, part of the ...

Targeting more than one viral protein has shown in the recent past to be effective: one of the mRNA COVID-19 shots was a bivalent vaccine that worked against two different strains of the virus.

FDA conducted a postmarketing observational study that assessed the risk of GBS following vaccination with the two companies ... the virus. A third approved product, Moderna's mRNA vaccine ...

A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug ...

A new experimental vaccine developed by researchers at MIT and Caltech could offer protection against emerging variants of SARS-CoV-2, as well as related coronaviruses, known as sarbecoviruses, that ...

Topics include a new warning on two respiratory syncytial virus (RSV) vaccines, the "Shkreli Awards," and a link between coffee drinking and lower mortality risk. After taking the quiz ...